---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-131525"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:11:22.219021+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences annual meeting elects directors; auditor ratification approved

## Summary
- Elected Richard Vincent, Shiv Kapoor, and David Gryska as Class II directors until 2028.
- David Gryska received 2,786,414 votes for and 1,313,237 withheld (32% withheld).
- Ratified KPMG LLP as independent auditor for FY2025 with 5,285,363 votes for, 2,987 against.
- 5,288,388 shares represented out of 6,583,382 outstanding (80.3% quorum).

## SEC filing metadata
- accession: 0001193125-25-131525
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312525131525/0001193125-25-131525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312525131525/d908206d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-131525
- JSON: https://secwatch.observer/filing/0001193125-25-131525.json
- Plain text: https://secwatch.observer/filing/0001193125-25-131525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.